...r eye diseases and leading causes of blindnessage-...thycan be reversed or even prevented by drugs that...esearchers at the University of Utah School of Med...d in a new study. , Damage from both diseases was...o4, was activated in mice models that simulate age...
...oneers in small RNA research--Victor Ambros, Gary ...recent discoveries at a special half-day symposium...0 p.m., Wednesday, April 16, in the Gore Recital H...nt will be held in their honor, as the 2008 winner...dal in Life Science. , UD,s symposium is part of ...
...nderstand how nitrogen accumulates in large rivers...Walter Dodds looked at small streams flowing close...sas State University, didn,t have to look any fart... Creek at K-State was one of nine small waterways ... nitrogen is removed from streams. With a grant fr...
Other Biology News:Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 3Pioneers in small RNA research to present at UD symposium, April 16 2Pioneers in small RNA research to present at UD symposium, April 16 3Research team finds that microorganisms filter nitrogen from small streams 2(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ -...d & Drug Administration (SFDA) has approved th...ts oral insulin project,(Nodlin), an innovative in...oval allows Biolaxy to initiate its first phase I ...characteristic of high blood glucose and poor,meta...
(Date:11/24/2009)... The FBI recently approved the Pr...es participating in or generating DNA records for ... Madison, WI USA (PRWEB) -- The FBI recentl...m for use by laboratories participating in, or ge...ystem (NDIS). NDIS currently contains more than se...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRN...HTL), formerly Calotto Capital Inc., a leading pro...r the stem cell research and fertility clinic mark...lts for the third quarter ended September 30, 2009...$1.46 million compared with $1.43 million in Q3 20...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-First...A ) announced today that the company is schedule...th Care Conference on December 1, 2009 at 11:30 a....w York Palace Hotel in New York City. Jack Lief, A...cheduled to provide an overview of the company, in...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3...ANCOUVER and SAN DIEGO, Jan. 31 /PRNewswire-FirstC...ical-stage developer of drugs for infectious,disea...py arm to its,currently enrolling Phase II viral k...nt-naive patients. The protocol amendment to this ... Review Board (IRB) approvals. The,purpose of this...
...oundation Continues Research Initiatives in Search... for Paralysis, SHORT HILLS, N.J., Jan. 31 The...ch is dedicated to curing spinal cord injury by,fu...y of life for people,living with paralysis through... it has awarded $1,996,745 million to 16 laborator...
...ILLBROOK, N.Y., Jan. 31 Mr. Donald Fresne, Chairm...he company has recently,obtained from Harvard Univ...ts that cover certain technologies related to canc...chnologies, which were developed jointly,by scient...and the,Department of Biological Chemistry and Mol...
Other Biology Technology:MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 3MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 4MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 5MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 6Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 2Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 3Mouse Anti-ROCK-1 (cleaved) Monoclonal Antibody, Unconjugated from BioVision
Rabbit Anti-Cullin-1 Polyclonal Antibody, Unconjugated from AnaSpec
Feline IL-2 ELISpot Kit from R&D Systems
FluoSpheres® biotin-labeled microspheres, 1.0 µm, yellow-green fluorescent (505/515) *1% solids* from Molecular Probes (Invitrogen)
Biology Products: